Trial NCT04115254
Stereotactic Magnetic Resonance Guided Radiation Therapy
- Phase
- Not given
- Sponsor
- Dana-Farber Cancer Institute
- Conditions
- Pancreas Cancer; Lung Cancer; Renal Cancer; Adrenal Metastases; Prostate Cancer; Liver Metastases; Oligoprogressive Nodal Metastases; Metachronous Nodal Metastases; Synchronous Nodal Metastases; Mesothelioma; Spine Metastases; Brain Metastases; Borderline Resectable Pancreatic Carcinoma
- Ages
- 18+ years
Eligibility criteria
Highlighted: restrictions our model extracted, each a verbatim quote (pink = excludes outright, blue = only under conditions).
Inclusion Criteria:
* Participants must have a confirmed malignancy requiring stereotactic body radiation therapy. See specific disease site cohorts for more details.
* Tumor size ≤ 7cm
* Age 18 years of older.
* ECOG performance status ≤2 (Karnofsky ≥60%, see Appendix A)Performance status
* Ability to understand and the willingness to sign a written informed consent document.
* Specific eligibility requirements for each disease site with be covered in each specific cohort.
Exclusion Criteria:
* Specific exclusion requirements for each disease site with be covered in each specific cohort
* History of allergic reactions attributed to gadolinium-based IV contrast.
-- Note: If a patient will not receive contrast, this is not applicable
* Pregnant women are excluded from this study.Pregnancy
* Severe claustrophobia or anxiety
* Participants who cannot undergo an MRI
Restrictions found (2)
- Performance statusOutrightinclusion
ECOG ≤ 2; Karnofsky ≥ 60%
Show in the text - PregnancyOutrightexclusionShow in the text
Recruiting in Massachusetts
- Brigham & Women's Hospital · Boston, Suffolk County
- Dana Farber Cancer Institute · Boston, Suffolk County